These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17539968)

  • 1. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
    Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
    Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
    Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
    Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
    Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size.
    Takahashi M; Kamei Y; Ezaki O
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E117-24. PubMed ID: 15353408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
    Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
    Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.
    Rong JX; Qiu Y; Hansen MK; Zhu L; Zhang V; Xie M; Okamoto Y; Mattie MD; Higashiyama H; Asano S; Strum JC; Ryan TE
    Diabetes; 2007 Jul; 56(7):1751-60. PubMed ID: 17456854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
    Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
    J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
    Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brown vs white adipocytes: the PPARgamma coregulator story.
    Koppen A; Kalkhoven E
    FEBS Lett; 2010 Aug; 584(15):3250-9. PubMed ID: 20600006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
    Liang HJ; Suk FM; Wang CK; Hung LF; Liu DZ; Chen NQ; Chen YC; Chang CC; Liang YC
    Chem Biol Interact; 2009 Oct; 181(3):309-15. PubMed ID: 19682441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
    Verreth W; Ganame J; Mertens A; Bernar H; Herregods MC; Holvoet P
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):922-8. PubMed ID: 16456093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliclazide inhibits proliferation but stimulates differentiation of white and brown adipocytes.
    Nakano N; Miyazawa N; Sakurai T; Kizaki T; Kimoto K; Takahashi K; Ishida H; Takahashi M; Suzuki K; Ohno H
    J Biochem; 2007 Nov; 142(5):639-45. PubMed ID: 17965069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
    Devasthale PV; Chen S; Jeon Y; Qu F; Shao C; Wang W; Zhang H; Cap M; Farrelly D; Golla R; Grover G; Harrity T; Ma Z; Moore L; Ren J; Seethala R; Cheng L; Sleph P; Sun W; Tieman A; Wetterau JR; Doweyko A; Chandrasena G; Chang SY; Humphreys WG; Sasseville VG; Biller SA; Ryono DE; Selan F; Hariharan N; Cheng PT
    J Med Chem; 2005 Mar; 48(6):2248-50. PubMed ID: 15771468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents.
    Lanne B; Dahllöf B; Lindahl C; Ebefors K; Kanmert I; von Bahr H; Miliotis T; Nyström AC; Arnerup G; Paulsons I; Kerb S; Oakes N
    J Proteome Res; 2006 Aug; 5(8):1850-9. PubMed ID: 16889406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.